These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9824145)

  • 1. Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats.
    Palmen MJ; Dieleman LA; Soesatyo M; Peña AS; Meuwissen SG; van Rees EP
    Dig Dis Sci; 1998 Nov; 43(11):2518-25. PubMed ID: 9824145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of altered neural function in a rat model of acute colitis.
    Jacobson K; McHugh K; Collins SM
    Gastroenterology; 1997 Jan; 112(1):156-62. PubMed ID: 8978354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
    Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
    Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical anticolitic efficacy and selectivity of the glucocorticoid budesonide in a new model of acetic acid-induced acute colitis in the rat.
    Fabia R; Ar'Rajab A; Willén R; Brattsand R; Erlansson M; Svensjö E
    Aliment Pharmacol Ther; 1994 Aug; 8(4):433-41. PubMed ID: 7986968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice.
    Ocón B; Aranda CJ; Gámez-Belmonte R; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F
    Biochem Pharmacol; 2016 Sep; 116():73-88. PubMed ID: 27431777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide.
    Ekström GM; Andersson SE
    Scand J Gastroenterol; 2000 Feb; 35(2):190-7. PubMed ID: 10720119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis.
    Palmen MJ; Dieleman LA; van der Ende MB; Uyterlinde A; Peña AS; Meuwissen SG; van Rees EP
    Clin Exp Immunol; 1995 Feb; 99(2):226-32. PubMed ID: 7851016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific delivery of budesonide with azopolymer-coated pellets: therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H; Fujita T; Komoike J; Kim SI; Terashima H; Muranishi S; Okabe S; Yamamoto A
    J Pharm Pharmacol; 1999 Mar; 51(3):257-61. PubMed ID: 10344625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A budesonide prodrug accelerates treatment of colitis in rats.
    Cui N; Friend DR; Fedorak RN
    Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
    Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
    J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
    Santos FA; Silva RM; Campos AR; De Araújo RP; Lima Júnior RC; Rao VS
    Food Chem Toxicol; 2004 Apr; 42(4):579-84. PubMed ID: 15019181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat.
    Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Cantoni A; Grandi D; Giovannini E; Coruzzi G
    Pharmacology; 2005 Jun; 74(3):135-42. PubMed ID: 15756055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of budesonide and probiotics enemas on the systemic inflammatory response of rats with experimental colitis.
    Souza MM; Aguilar-Nascimento JE; Dock-Nascimento DB
    Acta Cir Bras; 2007; 22 Suppl 1():40-5. PubMed ID: 17505654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.
    Date AA; Halpert G; Babu T; Ortiz J; Kanvinde P; Dimitrion P; Narayan J; Zierden H; Betageri K; Musmanno O; Wiegand H; Huang X; Gumber S; Hanes J; Ensign LM
    Biomaterials; 2018 Dec; 185():97-105. PubMed ID: 30236840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
    Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis.
    Marques CC; Castelo-Branco MT; Pacheco RG; Buongusto F; do Rosário A; Schanaider A; Coutinho-Silva R; de Souza HS
    Biochim Biophys Acta; 2014 Jan; 1842(1):65-78. PubMed ID: 24184714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.